Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China.
The School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Province Engineering Centre for Molecular Probe & Biomedicine Imaging, Guangzhou 510006, China.
Bioorg Chem. 2021 Jan;106:104433. doi: 10.1016/j.bioorg.2020.104433. Epub 2020 Oct 31.
The G-quadruplex (G4) DNA, which has been developed as a potential anticancer target in drug screening and design, plays a crucial role in the oncogene transcription and translation. Tanshinone IIA derivatives with a planar heterocycle structure may function as G4 stabilizers. We present an innovative case of imidazole-based tanshinone IIA derivatives (1-8) especially compound 4 that improve the selectivity and the binding affinity with G4 DNA and enhance the target tumor inhibition. Cellular and in vivo experiments indicate that the tanshinone IIA derivative 4 inhibits the growth, metastasis, and angiogenesis of triple-negative breast cancer cells possibly through the stabilization of multiple G4 DNAs (e.g., c-myc, K-ras, and VEGF) to induce DNA damage. Further investigation of the intermolecular interaction and the molecular docking indicates that tanshinone IIA derivatives have better selective binding capability to various G4 DNAs than to double-stranded DNA. These findings provide guidance in modifying the molecular structures of tanshinone IIA derivatives and reveal their potential to function as specific G4 stabilizers.
G-四链体(G4)DNA 已被开发为药物筛选和设计中的潜在抗癌靶标,在癌基因转录和翻译中发挥着关键作用。具有平面杂环结构的丹参酮 IIA 衍生物可能作为 G4 稳定剂发挥作用。我们提出了一种基于咪唑的丹参酮 IIA 衍生物(1-8)的创新案例,特别是化合物 4,它提高了与 G4 DNA 的选择性和结合亲和力,并增强了靶肿瘤抑制作用。细胞和体内实验表明,丹参酮 IIA 衍生物 4 通过稳定多种 G4 DNA(例如 c-myc、K-ras 和 VEGF)来诱导 DNA 损伤,从而抑制三阴性乳腺癌细胞的生长、转移和血管生成。对分子间相互作用和分子对接的进一步研究表明,丹参酮 IIA 衍生物对各种 G4 DNA 的选择性结合能力优于双链 DNA。这些发现为修饰丹参酮 IIA 衍生物的分子结构提供了指导,并揭示了它们作为特定 G4 稳定剂的潜力。